-
Perform a Google search of "low-dose naltrexone" and you will find a myriad of anecdotal testimonies to the benefits of the drug in a wide range of diseases including fibromyalgia. Now a small study suggests that naltrexone may be of some benefit in this difficult condition.
-
For patients with glucocorticoid-induced osteoporosis, a once-yearly infusion of zoledronic acid is as effective as daily risedronate for the prevention and treatment of bone loss according to a new study from Lancet.
-
Plan B, the so-called "morning after pill" will soon be available to women age 17 and older without a prescription.
-
-
The Canadian Association of Gastroenterology Consensus Group has published guidelines on use of long-term NSAIDs in patients at risk for GI bleeding and cardiovascular disease.
-
A survey of U.S. primary care physicians found that although most recommend weight loss to their obese patients, they do not utilize current evidence-based recommendations, and they underestimate the therapeutic effects of small weight losses.
-
Brown adipose tissue is involved in temperature regulation, and relates to metabolic rate and body mass index. Its activity appears to be reduced in people who are obese.
-
Patients with chronic heart failure (CHF) report progressively worse dyspnea with exercise, ranging from Class I NYHA (symptoms only present with strenuous exercise) to Class IV NYHA (symptoms present with any activity, even at rest).
-
-
Despite a clear-cut association between asthma and gastroesophageal reflux, aggressive PPI treatment had no clinical effect on poorly controlled asthma.
